CUBIST PHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | |
|---|---|---|---|---|---|---|
| Revenue | $229.9M | $211.7M | $754.0M | $636.5M | $562.1M | $433.6M |
| Operating income | $26.4M | $237.1M | $132.5M | $189.6M | $137.8M | $90.9M |
| Net income | — | — | — | $94.3M | $79.6M | $127.9M |
| Total assets | $3.15B | $1.93B | $1.88B | $1.42B | $983.7M | — |
| Total liabilities | $1.75B | $941.6M | $1.08B | $751.7M | $513.0M | — |
| Equity | $1.39B | $990.7M | $799.9M | $663.4M | $470.6M | $352.3M |
| EPS (diluted) | $0.09 | $0.45 | $0.52 | $1.55 | $1.36 | $2.07 |
| Shares out. | 64.9M | 62.9M | 59.5M | 59.3M | 58.0M | 68.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2013- Operating margin
- 11.5%
- Net margin
- —
- Return on equity
- —
- Return on assets
- —
- Return on capital (ROCE)
- 0.9%
- Liabilities / assets
- 55.7%
- Debt / equity
- 1.26×
- Book value / share
- $21.47
- Revenue growth (YoY)
- 8.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2013- Altman Z″ (distress)
- 2.09grey zone
- Piotroski F-Score
- 1/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 3 good- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Soeters Martinus HermanusDirector | Jan 21, 2015 | J | 10,397 | $102.00 |
| Moulder Leon O JrDirector | Jan 21, 2015 | J | 11,101 | $102.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsJan 21, 2015
- Other material eventJan 13, 2015
- Other material eventJan 2, 2015
- Other material eventDec 22, 2014
- Item 5.04Dec 19, 2014
- Other material eventDec 9, 2014
- Entered a material agreement · Director / officer change · Amended charter or bylaws · Other material eventDec 8, 2014
- Director / officer changeNov 6, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC TO-I/AAMENDMENT NO. 2 TO SCHEDULE TOFeb 23, 2015
- SC 13GFeb 17, 2015
- SC 13G/AFeb 13, 2015
- SC 13G/AFeb 10, 2015
- SC 13G/AFeb 10, 2015
- 15-12BFeb 2, 2015
- SC TO-I/AJan 28, 2015
- 25Jan 23, 2015
- SC TO-IJan 22, 2015
- 25-NSEJan 22, 2015
- SC TO-T/AAMENDMENT NO. 10Jan 22, 2015
- 4Jan 21, 2015
- 4Jan 21, 2015
- 4Jan 21, 2015
- 4Jan 21, 2015
Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.